Reports of a strong correlation between the presence of anti-HuD antibodies and spontaneous remission of SCLC in some patients suggest that the HuD-antigen might be a specific molecular target for immunotherapy [11,12]. The gene discussed is ELAVL4; the disease is small cell lung carcinoma.